Patients with lower extremity peripheral arterial disease may not walk far or fast enough to induce muscle ischemic symptoms because of comorbidities such as pulmonary disease or arthritis, may have atypical symptoms unrecognized as intermittent claudication [2] , may fail to mention their symptoms to their physician, or may have sufficient collateral arterial channels to tolerate their arterial obstruction. Women with lower extremity peripheral arterial disease have a higher prevalence of leg pain on exertion and at rest, poorer functioning, and greater walking impairment from leg symptoms than men with lower extremity peripheral arterial disease [3] . Poorer leg strength in women contributes to poorer lower extremity functioning in women with lower extremity peripheral arterial disease than in men with lower extremity peripheral arterial disease [3] . Women with lower extremity peripheral arterial disease develop a faster functional decline than men with lower extremity peripheral arterial disease [4] . More sedentary hours and slower outdoor walking speed are associated with faster decreases in functioning and adverse calf muscle changes in lower extremity peripheral arterial disease [5] . Increased physical activity levels during daily life are associated with less functional decline in patients with lower extremity peripheral arterial disease [6] .
Exercise rehabilitation programs have been demonstrated to increase walking distance in patients with intermittent claudication due to lower extremity peripheral arterial disease through improvements in peripheral circulation, walking economy, and cardiopulmonary function [7, 8] . The optimal exercise program for improving claudication pain distance in patients with lower extremity peripheral arterial disease uses intermittent walking to near-maximal pain during a program of at least 6 months [9] . Strength training is less effective than treadmill walking [10] . The American College of Cardiology/ American Heart Association guidelines recommend a supervised exercise program for patients with intermittent claudication due to lower extremity peripheral arterial disease [11] .
Supervised exercise training is recommended for a minimum of 30-45 minutes in sessions performed at least 3 times per week for a minimum of 12 weeks and preferably for 6 months or longer [9] . Among patients with lower extremity peripheral arterial disease, self-directed walking exercise performed at least 3 times weekly is associated with significantly less functional decline during the subsequent year [12] . Exercise training improves skeletal muscle intermediary metabolism, endothelial function, and gait biomechanics in patients with lower extremity peripheral arterial disease [13] . The increased peak exercise performance after treadmill training was associated with skeletal muscle denervation [13] .
A 12 week program of supervised exercise improves exercise performance and quality of life in patients with lower extremity peripheral arterial disease [10] . A supervised exercise training program is more effective than a nonstructured community walking program in improving exercise performance and quality of life in these patients [14] . Supervised exercise training programs are also associated with reduced cardiovascular mortality and reduced all-cause mortality in patients with lower extremity peripheral arterial disease [15, 16] . On the basis of the available data, the American College of Cardiology/ American Heart Association 2013 guidelines recommend a supervised walking exercise program in patients with lower extremity peripheral arterial disease with a Class Ia recommendation and unsupervised exercise with a Class IIb recommendation [17] .
Patients with intermittent claudication should be considered for revascularization to improve symptoms only in the absence of other disease that would limit exercise improvement such as angina pectoris, heart failure, chronic pulmonary disease, or orthopedic limitations [11] . However, 6-month outcomes from 111 patients with claudication due to aortoiliac peripheral arterial disease randomized to optimal medical therapy, optimal medical therapy plus supervised exercise, or optimal medical therapy plus stent revascularization in the Exercise Versus Endoluminal Revascularization (CLEVER) study showed that the greatest increase in treadmill walking performance occurred in the patients randomized to optimal medical therapy plus supervised exercise [18] .
The Endovascular Revascularization and Supervised Exercise (ERASE) trial randomized 212 patients with intermittent claudication due to lower extremity peripheral arterial disease to either endovascular revascularization plus supervised exercise or supervised exercise alone [19] . The follow-up duration of this study was 12 months. Endovascular revascularization plus supervised exercise improved the primary endpoint of maximum treadmill walking distance 1237 meters (from 264 meters to 101 meters), whereas supervised exercise alone improved the maximum treadmill walking distance 955 meters (from 285 meters to 1240 meters). Endovascular revascularization plus supervised exercise improved pain-free walking distance 1120 meters (from 117 meters to 1237 meters), whereas supervised exercise alone improved the maximum treadmill walking distance 712 meters (from 135 meters to 847 meters). Endovascular revascularization plus supervised exercise also improved quality-of-life scores more than did supervised exercise alone [19] .
A Dutch randomized trial demonstrated that endovascular revascularization had a similar benefit but higher costs per patient than a hospital-based exercise program [20] . Another study from a Dutch database of 4,954 patients showed that a stepped approach of using supervised exercise followed by endovascular revascularization was more cost effective than endovascular revascularization alone in patients with intermittent claudication due to lower extremity peripheral arterial disease [21] . Future research studies in patients with intermittent claudication due to lower extremity peripheral arterial disease should address not only the clinical benefits of a combined program of supervised exercise plus limb revascularization but also the ability of this treatment approach to be used by appropriate patients with desired improvements in functional outcomes.
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